Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast?

[1]  Joshua A. Kritzer,et al.  Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models , 2010, Disease Models & Mechanisms.

[2]  R. Nicoll,et al.  Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis , 2010, Neuron.

[3]  Yoshiaki Kamada,et al.  Dynamics and diversity in autophagy mechanisms: lessons from yeast , 2009, Nature Reviews Molecular Cell Biology.

[4]  S. Lindquist,et al.  Amyloid deposits: Protection against toxic protein species? , 2009, Cell cycle.

[5]  S. Lindquist,et al.  Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+] , 2009, Nature Structural &Molecular Biology.

[6]  D. Pearce,et al.  Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2. , 2009, Biochemical and biophysical research communications.

[7]  Joshua A. Kritzer,et al.  Rapid Selection of Cyclic Peptides that Reduce α-Synuclein Toxicity in Yeast and Animal Models , 2009, Nature chemical biology.

[8]  M. MacDonald,et al.  Rrs1 Is Involved in Endoplasmic Reticulum Stress Response in Huntington Disease* , 2009, The Journal of Biological Chemistry.

[9]  Sandra Codlin,et al.  S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p , 2009, Journal of Cell Science.

[10]  B. Popko,et al.  Endoplasmic reticulum stress in disorders of myelinating cells , 2009, Nature Neuroscience.

[11]  D. Sept,et al.  Neurodegeneration mutations in dynactin impair dynein-dependent nuclear migration , 2009, Proceedings of the National Academy of Sciences.

[12]  D. Karger,et al.  Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity , 2009, Nature Genetics.

[13]  Christer S. Ejsing,et al.  Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry , 2009, Proceedings of the National Academy of Sciences.

[14]  S. Lindquist,et al.  α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity , 2009, Nature Genetics.

[15]  W. Scheper,et al.  Endoplasmic reticulum protein quality control in neurodegenerative disease: the good, the bad and the therapy. , 2009, Current medicinal chemistry.

[16]  Martin L. Duennwald,et al.  Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. , 2008, Genes & development.

[17]  Corey Nislow,et al.  Yeast chemical genomics and drug discovery: an update. , 2008, Trends in pharmacological sciences.

[18]  M. Greenwood,et al.  The pleiotropic effects of heterologous Bax expression in yeast. , 2008, Biochimica et biophysica acta.

[19]  J. Winderickx,et al.  Protein folding diseases and neurodegeneration: lessons learned from yeast. , 2008, Biochimica et biophysica acta.

[20]  G. Perkins,et al.  Mitochondrial fragmentation in neurodegeneration , 2008, Nature Reviews Neuroscience.

[21]  K. M. Leach,et al.  Mitochondrial death pathways in yeast and mammalian cells. , 2008, Biochimica et biophysica acta.

[22]  S. Lindquist,et al.  A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity , 2008, Proceedings of the National Academy of Sciences.

[23]  Robert P. St.Onge,et al.  The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes , 2008, Science.

[24]  B. Ritz,et al.  Statin use and the risk of Parkinson disease , 2008, Neurology.

[25]  Ian Dunham,et al.  A systematic library for comprehensive overexpression screens in Saccharomyces cerevisiae , 2008, Nature Methods.

[26]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[27]  S. Lindquist,et al.  The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis , 2008, Proceedings of the National Academy of Sciences.

[28]  J. Trojanowski,et al.  Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. , 2007, Molecular biology of the cell.

[29]  P. Macreadie,et al.  Alzheimer's Aβ fused to green fluorescent protein induces growth stress and a heat shock response , 2007 .

[30]  W. Feindel.  The physiologist and the neurosurgeon: the enduring influence of Charles Sherrington on the career of Wilder Penfield. , 2007, Brain : a journal of neurology.

[31]  A. Young,et al.  A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse , 2007, Proceedings of the National Academy of Sciences.

[32]  S. Lindquist,et al.  A suite of Gateway® cloning vectors for high‐throughput genetic analysis in Saccharomyces cerevisiae , 2007, Yeast.

[33]  H. Zoghbi,et al.  Trinucleotide repeat disorders. , 2007, Annual review of neuroscience.

[34]  R. Shi,et al.  YGR198w (YPP1) targets A30P α-synuclein to the vacuole for degradation , 2007, The Journal of cell biology.

[35]  J. Toldi,et al.  Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders , 2007, Journal of the Neurological Sciences.

[36]  H. True,et al.  Prion Protein Repeat Expansion Results in Increased Aggregation and Reveals Phenotypic Variability , 2007, Molecular and Cellular Biology.

[37]  M. Tuite,et al.  Development of a Novel Yeast Cell-Based System for Studying the Aggregation of Alzheimer’s Disease-Associated Aβ Peptides in vivo , 2007, Neurodegenerative Diseases.

[38]  Karl Herrup,et al.  Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? , 2007, Nature Reviews Neuroscience.

[39]  J. Hay.  Faculty Opinions recommendation of Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. , 2007 .

[40]  S. Henry,et al.  The emergence of yeast lipidomics. , 2007, Biochimica et biophysica acta.

[41]  Leonidas Stefanis,et al.  α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.

[42]  Leslie Michels Thompson,et al.  Drosophila in the Study of Neurodegenerative Disease , 2006, Neuron.

[43]  S. Liebman,et al.  Modulation of Aβ42 low-n oligomerization using a novel yeast reporter system , 2006, BMC Biology.

[44]  J. Frydman,et al.  The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions , 2006, Nature Cell Biology.

[45]  Susan Lindquist,et al.  Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. , 2006, Human molecular genetics.

[46]  Jan Gründemann,et al.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.

[47]  Jennifer Apodaca,et al.  Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response. , 2006, Biochemical and biophysical research communications.

[48]  Inmar E. Givoni,et al.  Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast , 2006, Cell.

[49]  P. Tien,et al.  In vitro self‐propagation of recombinant PrPSc‐like conformation generated in the yeast cytoplasm , 2006, FEBS letters.

[50]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[51]  Susan Lindquist,et al.  Flanking sequences profoundly alter polyglutamine toxicity in yeast. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Susan Lindquist,et al.  A network of protein interactions determines polyglutamine toxicity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  F. Severin,et al.  Expression of an expanded polyglutamine domain in yeast causes death with apoptotic markers. , 2006, Biochimica et biophysica acta.

[54]  F. Giorgini,et al.  Yeast as a drug discovery platform in Huntington's and Parkinson's diseases , 2006, Biotechnology journal.

[55]  J. Winderickx,et al.  A yeast-based model of α-synucleinopathy identifies compounds with therapeutic potential , 2006 .

[56]  M. Snyder,et al.  Yeast as a Model for Human Disease , 2006, Current protocols in human genetics.

[57]  D. Rubinsztein,et al.  Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. , 2005, Human molecular genetics.

[58]  C. A. Froelich,et al.  Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. , 2005, Journal of molecular biology.

[59]  J. Keller,et al.  α-Synuclein Alters Proteasome Function, Protein Synthesis, and Stationary Phase Viability* , 2005, Journal of Biological Chemistry.

[60]  J. Jankovic.  Searching for a relationship between manganese and welding and Parkinson’s disease , 2005, Neurology.

[61]  Paolo Guidetti,et al.  A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease , 2005, Nature Genetics.

[62]  R. Zweig,et al.  α-Synuclein Targets the Plasma Membrane via the Secretory Pathway and Induces Toxicity in Yeast , 2005, Genetics.

[63]  A. Young,et al.  A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[64]  I. Braakman,et al.  Endoplasmic Reticulum Stress and the Making of a Professional Secretory Cell , 2005, Critical reviews in biochemistry and molecular biology.

[65]  A. Munn,et al.  Ncr1p, the Yeast Ortholog of Mammalian Niemann Pick C1 Protein, is Dispensable for Endocytic Transport , 2004, Traffic.

[66]  Mark R. Segal,et al.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.

[67]  Peter Breuer,et al.  Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. , 2004, Molecular cell.

[68]  A. Barberis,et al.  Searching for the most effective screening system to identify cell-active inhibitors of β-secretase , 2004, Biological chemistry.

[69]  S. Lindquist,et al.  Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology , 2003, Science.

[70]  Susan Lindquist,et al.  Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein , 2003, Science.

[71]  Richard Paylor,et al.  Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.

[72]  V. Malhotra,et al.  Rothman and Schekman SNAREd by Lasker for Trafficking , 2002, Cell.

[73]  Y. Chernoff,et al.  Huntingtin toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1 , 2002, The Journal of cell biology.

[74]  John Calvin Reed,et al.  Yeast and apoptosis , 2002, Nature Reviews Molecular Cell Biology.

[75]  J. Olson,et al.  Altered transcription in yeast expressing expanded polyglutamine , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[76]  S. Lindquist,et al.  Investigating protein conformation-based inheritance and disease in yeast. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[77]  E. Wanker,et al.  Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[78]  S. Lindquist,et al.  Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[79]  S. Lindquist,et al.  De novo generation of a PrPSc-like conformation in living cells , 1999, Nature Cell Biology.

[80]  D. Pearce,et al.  Hereditary spastic paraplegia: mitochondrial metalloproteases of yeast , 1999, Human Genetics.

[81]  T. Ferea,et al.  Action of BTN1, the yeast orthologue of the gene mutated in Batten disease , 1999, Nature Genetics.

[82]  D. Pain,et al.  The yeast connection to Friedreich ataxia. , 1999, American journal of human genetics.

[83]  P. Brown,et al.  Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.

[84]  David Botstein,et al.  Yeast as a Model Organism , 1997, Science.

[85]  F. Foury,et al.  Human genetic diseases: a cross-talk between man and yeast. , 1997, Gene.

[86]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[87]  D. Valle,et al.  A Saccharomyces cerevisiae homolog of the human adrenoleukodystrophy transporter is a heterodimer of two half ATP-binding cassette transporters. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Douglas E. Bassett,et al.  Yeast genes and human disease , 1996, Nature.

[89]  Hugo J. Bellen,et al.  Synaptotagmin controls and modulates synaptic-vesicle fusion in a Ca2+-dependent manner , 1995, Trends in Neurosciences.

[90]  D. Botstein,et al.  Yeast: an experimental organism for modern biology. , 1988, Science.

[91]  P. Matthews,et al.  Evidence from the use of vibration during procaine nerve block that the spindle group II fibres contribute excitation to the tonic stretch reflex of the decerebrate cat , 1973, The Journal of physiology.

[92]  D. Denny-Brown.  The Sherrington school of physiology. , 1957, Journal of neurophysiology.

[93]  C. Sherrington.  Sir Charles Sherrington´s first use of diphteria antitoxin made in England , 1948, Notes and Records of the Royal Society of London.

[94]  C. Sherrington,et al.  GOWER'S TRACT AND SPINAL BORDER CELLS , 1940 .

[95]  C S Sherrington,et al.  Reflex summation in the ipsilateral spinal flexion reflex , 1930, The Journal of physiology.

[96]  C. Sherrington.  Ferrier lecture.—Some functional problems attaching to convergence , 1929 .

[97]  C. Sherrington,et al.  Subliminal fringe in spinal flexion , 1928, The Journal of physiology.

[98]  Charles S. Sherrington,et al.  Remarks on some Aspects of Reflex Inhibition , 1925 .

[99]  C. Sherrington,et al.  REFLEX INHIBITION AS A FACTOR IN THE CO‐ORDINATION OF MOVEMENTS AND POSTURES , 1913 .

[100]  C S Sherrington,et al.  Observations on some spinal reflexes and the interconnection of spinal segments , 1903, The Journal of physiology.

[101]  A Ruffini,et al.  On the Minute Anatomy of the Neuromuscular Spindles of the Cat, and on their Physiological Significance , 1898, The Journal of physiology.

[102]  C S Sherrington,et al.  Decerebrate Rigidity, and Reflex Coordination of Movements , 1898, The Journal of physiology.

[103]  C. Sherrington.  On the Anatomical Constitution of Nerves of Skeletal Muscles; with Remarks on Recurrent Fibres in the Ventral Spinal Nerve‐root , 1894, The Journal of physiology.

[104]  C. Sherrington.  Notes on the Arrangement of some Motor Fibres in the Lumbo‐Sacral Plexus , 1892, The Journal of physiology.

[105]  C. Sherrington,et al.  THE PATHOLOGICAL ANATOMY OF A CASE OF LOCOMOTOR ATAXY, WITH SPECIAL REFERENCE TO ASCENDING DEGENERATIONS IN THE SPINAL CORD AND MEDULLA OBLONGATA , 1888 .

[106]  I. Macreadie,et al.  A new method to measure cellular toxicity of non-fibrillar and fibrillar Alzheimer's Abeta using yeast. , 2008, Journal of Alzheimer's disease : JAD.

[107]  S. Lindquist,et al.  The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. , 2008, Proceedings of the National Academy of Sciences of the United States of America.

[108]  I. Macreadie,et al.  A New Method to Measure Cellular Toxicity of Non-Fibrillar and Fibrillar Alzheimer's Aβ Using Yeast , 2008 .

[109]  S. England,et al.  α-synuclein fission yeast model , 2007, Journal of Molecular Neuroscience.

[110]  P. Macreadie,et al.  Alzheimer's Abeta fused to green fluorescent protein induces growth stress and a heat shock response. , 2007, FEMS yeast research.

[111]  Brandon E. Johnson,et al.  alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress. , 2006, Journal of molecular neuroscience : MN.

[112]  J. Winderickx,et al.  A yeast-based model of alpha-synucleinopathy identifies compounds with therapeutic potential. , 2006, Biochimica et biophysica acta.

[113]  S. England,et al.  alpha-Synuclein fission yeast model: concentration-dependent aggregation without plasma membrane localization or toxicity. , 2006, Journal of molecular neuroscience : MN.

[114]  A. Lundberg,et al.  Spinal border cell origin of the ventral spinocerebellar tract , 2004, Experimental Brain Research.

[115]  S. Lindquist,et al.  Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. , 2003, Science.

[116]  F. Sherman.  Getting started with yeast. , 1991, Methods in enzymology.

[117]  K. Johnson.  An Update. , 1984, Journal of food protection.

[118]  C. Sherrington,et al.  Problems of Muscular Receptivity , 1924, Nature.

[119]  A. Ruffini.  Sulla fine anatomia dei fusi neuro-muscolari del gatto e sul loro significato fisiologico , 1898 .

[120]  C. Sherrington.  Further note on the sensory nerves of muscles , 1897, Proceedings of the Royal Society of London.

[121]  C. Sherrington,et al.  On reciprocal innervation of antagonistic muscles. Third note , 1897, Proceedings of the Royal Society of London.

[122]  C. Sherrington,et al.  Experiments in examination of the peripheral distribution of the fibres of the posterior roots of some spinal nerves. Part II , 1897, Proceedings of the Royal Society of London.

[123]  C. Sherrington.  II. Note on the knee-jerk and the correlation of action of antagonistic muscles , 1893, Proceedings of the Royal Society of London.

[124]  C. Sherrington.  XXXI. Note on the anatomy of asiatic cholera as exemplified in cases occurring in Italy in 1886 , 1887, Proceedings of the Royal Society of London.

[125]  C. Sherrington,et al.  Preliminary report on the pathology of Cholera Asiatica (as observed in Spain, 1885) , 1887, Proceedings of the Royal Society of London.

[126]  C. Sherrington,et al.  ON A CASE OF BILATERAL DEGENERATION IN THE SPINAL CORD, FIFTY-TWO DAYS AFTER HÆMORRHAGE IN THE CEREBRAL HEMISPHERE , 1886 .

[127]  W. Kühne.  Über die peripherischen Endorgane der motorischen Nerven , 1862 .